7T钠MRI用于射波刀立体定向放疗后颅内肿瘤早期疗效评估
本研究纳入16例患者共22个颅内肿瘤,在射波刀立体定向放疗前及治疗后48小时、1周、1个月行7T钠MRI,计算组织钠浓度(TSC)。肿瘤TSC信号显著高于正常组织,TSC变化可定量检测放疗后早期放射生物学改变。
要点
- 7T钠MRI可清晰显示颅内肿瘤瘤内信号,肿瘤TSC显著高于正常组织(t=5.250,P<.001)。
- 22个肿瘤的肿瘤/脑脊液TSC比值平均为0.66(范围0.23-1.5),对侧正常组织为0.30(范围0.15-0.43)。
- 治疗后48小时TSC平均较治疗前升高0.06,1周开始下降,1个月时10个肿瘤TSC继续下降、2个升高。
核心结论
- 7T钠MRI可定量检测TSC变化,用于检测射波刀放疗后颅内肿瘤早期放射生物学改变。
研究设计与样本
- 研究纳入2016年12月1日至2019年8月15日在本机构接受射波刀立体定向放疗的16例患者(12男4女,24-75岁)共22个颅内肿瘤,于放疗前及治疗后48小时、1周、1个月行7T钠MRI,基于手动标注的肿瘤区域计算TSC。
关键影像表现/征象
- 超高场7T钠MRI清晰显示瘤内信号,显著高于正常组织(t=5.250,P<.001),但水肿区有一定影响。
- 22个肿瘤的肿瘤/脑脊液TSC比值平均0.66(范围0.23-1.5),对侧正常组织0.30(范围0.15-0.43),水肿区0.58(范围0.25-1.21),额叶皮质0.25(范围0.17-0.42),额叶白质0.30(范围0.19-0.49)。
- 8例患者共12个肿瘤在治疗后48小时、1周、1个月接受扫描,治疗后48小时平均TSC较治疗前高0.06,1周开始下降。
- 1个月时10个肿瘤TSC比值继续下降、2个肿瘤升高;3个月后肿瘤体积缩小2.4%-99%。
诊断标准与关键数值
- 以手动标注肿瘤区域计算组织钠浓度(TSC),并以肿瘤/脑脊液TSC比值进行定量分析。
- 22个肿瘤肿瘤/脑脊液TSC比值平均0.66(范围0.23-1.5),对侧正常组织0.30(范围0.15-0.43)。
临床应用与阅片要点
- 7T钠MRI可在射波刀放疗后48小时、1周、1个月等早期时间点定量TSC,用于检测放射生物学改变。
- 判读时需注意水肿区对瘤内TSC信号的影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Conventionally, early treatment response to stereotactic radiotherapy in intracranial tumors is often determined by structural MR imaging. Tissue sodium concentration is altered by cellular integrity and energy status in cells. In this study, we aimed to investigate the feasibility of sodium MR imaging at 7T for the preliminary evaluation of radiotherapeutic efficacy for intracranial tumors.
MATERIALS AND METHODS: Data were collected from 16 patients (12 men and 4 women, 24-75 years of age) with 22 intracranial tumors who were treated with stereotactic radiation therapy using CyberKnife at our institution between December 1, 2016, and August 15, 2019. Sodium MR imaging was performed at 7T before and 48 hours, 1 week, and 1 month after CyberKnife radiation therapy. Tissue sodium concentration (TSC) was calculated and analyzed based on manually labeled regions of tumors.
RESULTS: Ultra-high-field sodium MR imaging clearly showed the intratumoral signal, which is significantly higher than that of normal tissue (t = 5.250, P <.001)., but the edema zone has some influence. The average TSC ratios of tumor to CSF in the 22 tumors, contralateral normal tissues, edema zones, frontal cortex, and frontal white matter were 0.66 (range, 0.23-1.5), 0.30 (range, 0.15-0.43), 0.58 (range, 0.25-1.21), 0.25 (range, 0.17-0.42), and 0.30 (range, 0.19-0.49), respectively. A total of 12 tumors in 8 patients were scanned at 48 hours, 1 week, and 1 month after treatment. The average TSC at 48 hours after treatment was 0.06 higher than that before treatment and began to decrease at 1 week. The TSC ratios of 10 continued to decline and 2 tumors increased at 1 month, respectively. Tumor volume decreased by 2.4%-99% after 3 months.
CONCLUSIONS: Changes in the TSC can be quantified by sodium MR imaging at 7T and used to detect radiobiologic alterations in intracranial tumors at early time points after CyberKnife radiation therapy.
引用
- Huang L, Bai J, Zong R, et al. Sodium MRI at 7T for Early Response Evaluation of Intracranial Tumors following Stereotactic Radiotherapy Using the CyberKnife. AJNR Am J Neuroradiol. 2022. PMID: 35121584. doi:10.3174/ajnr.A7404
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。